Katharina Habler

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Drug Administration

Liquid Chromatography Tandem Mass Spectrometry

St Segment Elevation Myocardial Infarction

Cystic Fibrosis

Top Venues

Clinical chemistry and laboratory medicine

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Katharina Habler, Arber Rexhaj, Felix L Happich, Michael Vogeser
Standardization via Post Column Infusion-A Novel and Convenient Quantification Approach for LC-MS/MS. Molecules (Basel, Switzerland) 29 (16) (2024)
Katharina Habler, Michael Paal, Felix Lucian Happich, Michael Vogeser
Pitfall in the analysis of the alcohol biomarkers ethyl glucuronide and ethyl sulfate by laboratory-caused contamination with disinfectants. Clinical chemistry and laboratory medicine (2022)
Katharina Habler, Bernhard Koeppl, Franz Bracher, Michael Vogeser
Targeted profiling of 24 sulfated and non-sulfated bile acids in urine using two-dimensional isotope dilution UHPLC-MS/MS. Clinical chemistry and laboratory medicine (2021)
Katharina Habler, Anne-Sophie Kalla, Michael Rychlik, Mathias Bruegel, Daniel Teupser, Susanne Nährig, Michael Vogeser, Michael Paal
Isotope dilution LC-MS/MS quantification of the cystic fibrosis transmembrane conductance regulator (CFTR) modulators ivacaftor, lumacaftor, tezacaftor, elexacaftor, and their major metabolites in human serum. Clinical chemistry and laboratory medicine 60 (1) (2021)
Michael Paal, Katharina Habler, Michael Vogeser
Mass spectrometric sample identification with indicator compounds introduced via labeled sample tubes. Clinical chemistry and laboratory medicine 59 (1) (2020)
Katharina Habler, Michael Paal, Michael Vogeser
Isotope dilution-LC-MS/MS method for quantification of the urinary cotinine-to-creatinine ratio. Clinical chemistry and laboratory medicine 58 (9) (2020)